Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
| In millions, except per share items | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues: |
| Hospital operations | 1,626.7 | 1,808.7 | 1,988.0 | | | |
| Quorum Health Resources | 59.7 | 70.9 | 80.9 | | | |
| All other | 3.2 | | 3.3 | | | |
| Total revenues | 1,689.6 | 1,878.6 | 2,072.2 | 2,419.1 | 14,059.7 | 13,115.2 |
| Revenue growth [+] | -10.1% | -9.3% | -14.3% | -82.8% | 7.2% | |
| Hospital operations | -10.1% | -9.0% | | | | |
| Quorum Health Resources | -15.8% | -12.4% | | | | |
| Cost of goods sold [+] | 1,624.2 | 1,850.6 | 2,040.1 | 1,034.2 | 2,025.4 | 2,002.9 |
| Labor costs | 838.0 | 929.9 | 1,034.8 | | 1,016.7 | 1,012.6 |
| Supplies costs | | | | | 249.8 | 244.6 |
| Other direct costs | 502.0 | 575.0 | 623.1 | 645.8 | 634.2 | 619.8 |
| Gross profit | 65.5 | 28.0 | 32.1 | 1,384.8 | 12,034.3 | 11,112.3 |
| Gross margin | 3.9% | 1.5% | 1.5% | 57.2% | 85.6% | 84.7% |
| Selling, general and administrative [+] | 44.3 | 47.0 | 50.2 | 1,107.0 | 48.7 | 48.3 |
| General and administrative [+] | 44.3 | 47.0 | 50.2 | 1,107.0 | 48.7 | 48.3 |
| Wages and related expenses | | | | 1,057.1 | | |
| Rent expense | 44.3 | 47.0 | 50.2 | 49.9 | 48.7 | 48.3 |
| Other operating expenses | -88.6 | -132.8 | -136.2 | 144.8 | 11,738.3 | 10,799.2 |
| EBITDA [+] | 109.7 | 113.8 | 118.0 | 133.0 | 247.3 | 264.8 |
| EBITDA growth | -3.6% | -3.6% | -11.3% | -46.2% | -6.6% | |
| EBITDA margin | 6.5% | 6.1% | 5.7% | 5.5% | 1.8% | 2.0% |
| Depreciation | 45.1 | 52.6 | 61.7 | 86.1 | 93.4 | 91.9 |
| EBITA | 64.6 | 61.3 | 56.4 | 46.9 | 153.9 | 173.0 |
| EBITA margin | 3.8% | 3.3% | 2.7% | 1.9% | 1.1% | 1.3% |
| Amortization of intangibles | 12.5 | 15.4 | 20.5 | 31.2 | 34.6 | 35.7 |
| EBIT [+] | 52.1 | 45.8 | 35.9 | 15.7 | 119.3 | 137.2 |
| EBIT growth | 13.6% | 27.7% | 128.2% | -86.8% | -13.0% | |
| EBIT margin | 3.1% | 2.4% | 1.7% | 0.7% | 0.8% | 1.0% |
| Non-recurring items [+] | 80.5 | 116.8 | 48.0 | 301.4 | 13.0 | 31.4 |
| Asset impairment | 42.8 | 77.1 | 47.3 | 291.9 | 13.0 | 1.0 |
| Loss (gain) on disposal of assets | 24.9 | 18.7 | | | | |
| Loss (gain) on sale of business | 3.1 | 9.0 | -5.2 | 2.2 | | |
| Legal settlement | 9.7 | 12.0 | 6.0 | 7.3 | | 30.4 |
| Interest expense | 132.4 | 128.1 | 122.1 | 113.4 | 98.3 | 92.9 |
| Interest expense | 132.4 | 128.1 | 122.1 | 113.4 | 98.3 | 92.9 |
| Pre-tax income | -160.8 | -199.1 | -134.2 | -399.1 | 8.0 | 12.9 |
| Income taxes | 1.2 | -0.8 | -21.9 | -53.9 | 3.3 | 5.6 |
| Tax rate | | 0.4% | 16.3% | 13.5% | 41.1% | 43.1% |
| Minority interest | 2.0 | 2.0 | 1.8 | 2.5 | 3.4 | -0.4 |
| Net income | -163.9 | -200.2 | -114.2 | -347.7 | 1.3 | 7.8 |
| Net margin | -9.7% | -10.7% | -5.5% | -14.4% | 0.0% | 0.1% |
| |
| Basic EPS [+] | ($5.47) | ($6.91) | ($4.06) | ($12.24) | $0.05 | $0.27 |
| Growth | -20.8% | 70.1% | -66.8% | -26104.0% | -82.9% | |
| Diluted EPS [+] | ($5.47) | ($6.91) | ($4.06) | ($12.24) | $0.05 | $0.27 |
| Growth | -20.8% | 70.1% | -66.8% | -26104.0% | -82.9% | |
| |
| Shares outstanding (basic) [+] | 30.0 | 29.0 | 28.1 | 28.4 | 28.4 | 28.4 |
| Growth | 3.4% | 3.1% | -1.1% | 0.0% | 0.0% | |
| Shares outstanding (diluted) [+] | 30.0 | 29.0 | 28.1 | 28.4 | 28.4 | 28.4 |
| Growth | 3.4% | 3.1% | -1.1% | 0.0% | 0.0% | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|